Bahriye Aktas

Summary

Country: Germany

Publications

  1. doi Validity of bone marker measurements for monitoring response to bisphosphonate therapy with zoledronic acid in metastatic breast cancer
    Bahriye Aktas
    Department of Gynecology and Obstetrics, University of Duisburg Essen, D 45122 Essen, Germany
    Oncol Rep 30:441-7. 2013
  2. ncbi Utility of mesothelin, L1CAM and Afamin as biomarkers in primary ovarian cancer
    Bahriye Aktas
    Department of Gynecology and Obstetrics, University of Duisburg Essen, Hufelandstrasse 55, D 45122 Essen, Germany
    Anticancer Res 33:329-36. 2013
  3. pmc Prospective evaluation of serum tissue inhibitor of metalloproteinase 1 and carbonic anhydrase IX in correlation to circulating tumor cells in patients with metastatic breast cancer
    Volkmar Muller
    Department of Gynecology, University Medical Center Hamburg Eppendorf, Martinistrasse 52, 20241 Hamburg, Germany
    Breast Cancer Res 13:R71. 2011
  4. pmc Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients
    Bahriye Aktas
    Department of Gynecology and Obstetrics, University Hospital Essen, University of Duisburg Essen, Hufelandstrasse 55, 45122 Essen, Germany
    Breast Cancer Res 11:R46. 2009
  5. doi Comparison of estrogen and progesterone receptor status of circulating tumor cells and the primary tumor in metastatic breast cancer patients
    Bahriye Aktas
    Department of Gynecology and Obstetrics, University of Essen, Hufelandstrase 55, 45122 Essen, Germany
    Gynecol Oncol 122:356-60. 2011
  6. doi Molecular profiling and prognostic relevance of circulating tumor cells in the blood of ovarian cancer patients at primary diagnosis and after platinum-based chemotherapy
    Bahriye Aktas
    Department of Gynecology and Obstetrics, University of Duisburg Essen, Essen, Germany
    Int J Gynecol Cancer 21:822-30. 2011
  7. pmc Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells
    Tanja Fehm
    Department of Gynecology and Obstetrics, Calwer Strasse 7, University Hospital of Tuebingen, D 72076 Tuebingen, Germany
    Breast Cancer Res 11:R59. 2009
  8. ncbi Effect of ibandronate on disseminated tumor cells in the bone marrow of patients with primary breast cancer: a pilot study
    Oliver Hoffmann
    Department of Gynecology and Obstetrics, University Hospital Essen, University of Duisburg Essen, Hufelandstrasse 55, D 45122 Essen, Germany
    Anticancer Res 31:3623-8. 2011
  9. pmc Definition of compartment-based radical surgery in uterine cancer: radical hysterectomy in cervical cancer as 'total mesometrial resection (TMMR)' by M Höckel translated to robotic surgery (rTMMR)
    Rainer Kimmig
    Department of Gynecology and Obstetrics, West German Cancer Center, University Clinic Essen, University of Duisburg Essen, Hufelandstrasse 55, Essen 45147, Germany
    World J Surg Oncol 11:211. 2013
  10. doi [(18)F]FDG PET/MRI vs. PET/CT for whole-body staging in patients with recurrent malignancies of the female pelvis: initial results
    Karsten Beiderwellen
    Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, University of Duisburg Essen, Hufelandstrasse 55, 45147, Essen, Germany
    Eur J Nucl Med Mol Imaging 42:56-65. 2015

Collaborators

Detail Information

Publications16

  1. doi Validity of bone marker measurements for monitoring response to bisphosphonate therapy with zoledronic acid in metastatic breast cancer
    Bahriye Aktas
    Department of Gynecology and Obstetrics, University of Duisburg Essen, D 45122 Essen, Germany
    Oncol Rep 30:441-7. 2013
    ....
  2. ncbi Utility of mesothelin, L1CAM and Afamin as biomarkers in primary ovarian cancer
    Bahriye Aktas
    Department of Gynecology and Obstetrics, University of Duisburg Essen, Hufelandstrasse 55, D 45122 Essen, Germany
    Anticancer Res 33:329-36. 2013
    ..We correlated these findings with clinical parameters and evaluated their prognostic value with regard to overall survival (OS)...
  3. pmc Prospective evaluation of serum tissue inhibitor of metalloproteinase 1 and carbonic anhydrase IX in correlation to circulating tumor cells in patients with metastatic breast cancer
    Volkmar Muller
    Department of Gynecology, University Medical Center Hamburg Eppendorf, Martinistrasse 52, 20241 Hamburg, Germany
    Breast Cancer Res 13:R71. 2011
    ..The aim of the study was to investigate whether serum concentrations of TIMP-1 and CAIX are associated with the detection of CTC in metastatic breast cancer...
  4. pmc Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients
    Bahriye Aktas
    Department of Gynecology and Obstetrics, University Hospital Essen, University of Duisburg Essen, Hufelandstrasse 55, 45122 Essen, Germany
    Breast Cancer Res 11:R46. 2009
    ....
  5. doi Comparison of estrogen and progesterone receptor status of circulating tumor cells and the primary tumor in metastatic breast cancer patients
    Bahriye Aktas
    Department of Gynecology and Obstetrics, University of Essen, Hufelandstrase 55, 45122 Essen, Germany
    Gynecol Oncol 122:356-60. 2011
    ..It was the purpose of the present study (1) to reevaluate the ER/PR expression by CTCs and (2) to compare the hormone receptor status expression profile of CTCs with the primary tumor...
  6. doi Molecular profiling and prognostic relevance of circulating tumor cells in the blood of ovarian cancer patients at primary diagnosis and after platinum-based chemotherapy
    Bahriye Aktas
    Department of Gynecology and Obstetrics, University of Duisburg Essen, Essen, Germany
    Int J Gynecol Cancer 21:822-30. 2011
    ..Results were compared with detection of DTC in BM...
  7. pmc Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells
    Tanja Fehm
    Department of Gynecology and Obstetrics, Calwer Strasse 7, University Hospital of Tuebingen, D 72076 Tuebingen, Germany
    Breast Cancer Res 11:R59. 2009
    ....
  8. ncbi Effect of ibandronate on disseminated tumor cells in the bone marrow of patients with primary breast cancer: a pilot study
    Oliver Hoffmann
    Department of Gynecology and Obstetrics, University Hospital Essen, University of Duisburg Essen, Hufelandstrasse 55, D 45122 Essen, Germany
    Anticancer Res 31:3623-8. 2011
    ..The purpose of our study was to: i) analyze the presence of DTCs in the BM of breast cancer patients 2-10 years after first diagnosis of cancer, and ii) to study the effect of ibandronate on DTCs in those patients with DTC persistence...
  9. pmc Definition of compartment-based radical surgery in uterine cancer: radical hysterectomy in cervical cancer as 'total mesometrial resection (TMMR)' by M Höckel translated to robotic surgery (rTMMR)
    Rainer Kimmig
    Department of Gynecology and Obstetrics, West German Cancer Center, University Clinic Essen, University of Duisburg Essen, Hufelandstrasse 55, Essen 45147, Germany
    World J Surg Oncol 11:211. 2013
    ..Robotic surgery may additionally reduce morbidity compared to open surgery. We describe robotically assisted total mesometrial resection (rTMMR) step by step in cervical cancer and present feasibility data from 26 patients...
  10. doi [(18)F]FDG PET/MRI vs. PET/CT for whole-body staging in patients with recurrent malignancies of the female pelvis: initial results
    Karsten Beiderwellen
    Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, University of Duisburg Essen, Hufelandstrasse 55, 45147, Essen, Germany
    Eur J Nucl Med Mol Imaging 42:56-65. 2015
    ..To evaluate the diagnostic potential of PET/MRI with [(18)F]FDG in recurrent ovarian and cervical cancer in comparison to PET/CT...
  11. doi Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer: an option for monitoring response to breast cancer related therapies
    Mitra Tewes
    Department of Internal Medicine Cancer Research, University Hospital Essen, University of Duisburg Essen, 45122, Essen, Germany
    Breast Cancer Res Treat 115:581-90. 2009
    ..We analyzed circulating tumor cells (CTC) in blood of metastatic breast cancer patients (n = 42) and determined the ability of this method to predict therapy response...
  12. doi HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial
    Tanja Fehm
    Department of Gynecology and Obstetrics, University of Tubingen, Calwer Strasse 7, 72076, Tubingen, Germany
    Breast Cancer Res Treat 124:403-12. 2010
    ..Therefore, it will be mandatory to correlate the assay-dependent HER2 status of CTCs to the clinical response on HER2-targeted therapies...
  13. doi ERCC1-positive circulating tumor cells in the blood of ovarian cancer patients as a predictive biomarker for platinum resistance
    Jan Dominik Kuhlmann
    Department of Gynecology and Obstetrics, West German Cancer Center, University Hospital of Essen, Essen, Germany Department of Gynecology and Obstetrics, Medical Faculty and University Hospital Carl Gustav Carus, Technische Universitat Dresden, Dresden, Germany German Cancer Consortium DKTK, Dresden and German Cancer Research Center DKFZ, Heidelberg, Germany
    Clin Chem 60:1282-9. 2014
    ....
  14. doi Detection of disseminated tumor cells in bone marrow and circulating tumor cells in blood of patients with early-stage male breast cancer
    Mitra Tewes
    Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University of Duisburg Essen, Hufelandstrasse 55, 45122, Essen, Germany
    J Cancer Res Clin Oncol 141:87-92. 2015
    ..Here, we explored whether disseminated tumor cells (DTC) in bone marrow (BM) and circulating tumor cells (CTC) in blood could be suitable biomarkers in male BC...
  15. pmc Definition of compartment based radical surgery in uterine cancer-part I: therapeutic pelvic and periaortic lymphadenectomy by Michael höckel translated to robotic surgery
    Rainer Kimmig
    Department Gynecology and Obstetrics University Clinic Essen, West German Cancer Center, University Duisburg Essen, Hufelandstrase 55, 45147 Essen, Germany
    ISRN Obstet Gynecol 2013:297921. 2013
    ..It should be analyzed in multicenter studies with extended followup on the basis of the described technique...
  16. pmc Correlation of standardized uptake value and apparent diffusion coefficient in integrated whole-body PET/MRI of primary and recurrent cervical cancer
    Johannes Grueneisen
    Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany
    PLoS ONE 9:e96751. 2014
    ..To evaluate a potential correlation of the maximum standard uptake value (SUVmax) and the minimum apparent diffusion coefficient (ADCmin) in primary and recurrent cervical cancer based on integrated PET/MRI examinations...